7
Views
21
CrossRef citations to date
0
Altmetric
Article

Multitasking C2H2 Zinc Fingers Link Zac DNA Binding to Coordinated Regulation of p300-Histone Acetyltransferase Activity

, &
Pages 5544-5557 | Received 28 Nov 2005, Accepted 27 Apr 2006, Published online: 27 Mar 2023

REFERENCES

  • Abdollahi, A., A. K. Godwin, P. D. Miller, L. A. Getts, D. C. Schultz, T. Taguchi, J. R. Testa, and T. C. Hamilton. 1997. Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells. Cancer Res. 57:2029–2034.
  • Alam, S., D. Zinyk, L. Ma, and C. Schuurmans. 2005. Members of the Plag gene family are expressed in complementary and overlapping regions in the developing murine nervous system. Dev. Dyn. 234:772–782.
  • Arima, T., T. Kamikihara, T. Hayashida, K. Kato, T. Inoue, Y. Shirayoshi, M. Oshimura, H. Soejima, T. Mukai, and N. Wake. 2005. Zac, Lit1 (Kcnq1Ot1) and P57(Kip2) (Cdkn1C) are in an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome. Nucleic Acids Res. 33:2650–2660.
  • Basyuk, E., V. Coulon, D. A. Le, M. Coisy-Quivy, J. P. Moles, A. Gandarillas, and L. Journot. 2005. The candidate tumor suppressor gene ZAC is involved in keratinocyte differentiation and its expression is lost in basal cell carcinomas. Mol. Cancer Res. 3:483–492.
  • Bilanges, B., A. Varrault, E. Basyuk, C. Rodriguez, A. Mazumdar, C. Pantaloni, J. Bockaert, C. Theillet, D. Spengler, and L. Journot. 1999. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors. Oncogene 18:3979–3988.
  • Bilanges, B., A. Varrault, A. Mazumdar, C. Pantaloni, A. Hoffmann, J. Bockaert, D. Spengler, and L. Journot. 2001. Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities. Oncogene 20:1246–1253.
  • Blanco, J. C., S. Minucci, J. Lu, X. J. Yang, K. K. Walker, H. Chen, R. M. Evans, Y. Nakatani, and K. Ozato. 1998. The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev. 12:1638–1651.
  • Bordoli, L., S. Husser, U. Luthi, M. Netsch, H. Osmani, and R. Eckner. 2001. Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity. Nucleic Acids Res. 29:4462–4471.
  • Ciani, E., A. Hoffmann, P. Schmidt, L. Journot, and D. Spengler. 1999. Induction of the PAC1-R (PACAP-type I receptor) gene by p53 and Zac. Mol. Brain Res. 69:290–294.
  • Debes, J. D., L. J. Schmidt, H. Huang, and D. J. Tindall. 2002. p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6. Cancer Res. 62:5632–5636.
  • Eckner, R., M. E. Ewen, D. Newsome, M. Gerdes, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869–884.
  • Felsenfeld, G., and M. Groudine. 2003. Controlling the double helix. Nature 421:448–453.
  • Fulco, M., R. L. Schiltz, S. Iezzi, M. T. King, P. Zhao, Y. Kashiwaya, E. Hoffman, R. L. Veech, and V. Sartorelli. 2003. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol. Cell 12:51–62.
  • Gayther, S. A., S. J. Batley, L. Linger, A. Bannister, K. Thorpe, S. F. Chin, Y. Daigo, P. Russell, A. Wilson, H. M. Sowter, J. D. Delhanty, B. A. Ponder, T. Kouzarides, and C. Caldas. 2000. Mutations truncating the EP300 acetylase in human cancers. Nat. Genet. 24:300–303.
  • Gillardon, F., R. Hata, and K. A. Hossmann. 1998. Delayed up-regulation of Zac1 and PACAP type I receptor after transient focal cerebral ischemia in mice. Mol. Brain Res. 61:207–210.
  • Goodman, R. H., and S. Smolik. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:1553–1577.
  • Grossman, S. R. 2001. p300/CBP/p53 interaction and regulation of the p53 response. Eur. J. Biochem. 268:2773–2778.
  • Hoffmann, A., E. Ciani, J. Boeckardt, F. Holsboer, L. Journot, and D. Spengler. 2003. Transcriptional activities of the zinc finger protein Zac are differentially controlled by DNA binding. Mol. Cell. Biol. 23:988–1003.
  • Huang, S. M., A. H. Schonthal, and M. R. Stallcup. 2001. Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1. Oncogene 20:2134–2143.
  • Huang, S. M., and M. R. Stallcup. 2000. Mouse Zac1, a transcriptional coactivator and repressor for nuclear receptors. Mol. Cell. Biol. 20:1855–1867.
  • Ito, A., C. H. Lai, X. Zhao, S. Saito, M. H. Hamilton, E. Appella, and T. P. Yao. 2001. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J. 20:1331–1340.
  • Janknecht, R., and T. Hunter. 1996. Transcription. A growing coactivator network. Nature 383:22–23.
  • Kadonaga, J. T. 2004. Regulation of RNA polymerase II transcription by sequence-specific DNA binding factors. Cell 116:247–257.
  • Korzus, E., J. Torchia, D. W. Rose, L. Xu, R. Kurokawa, E. M. McInerney, T. M. Mullen, C. K. Glass, and M. G. Rosenfeld. 1998. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279:703–707.
  • Kouzarides, T. 2000. Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19:1176–1179.
  • Lee, D. Y., J. J. Hayes, D. Pruss, and A. P. Wolffe. 1993. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72:73–84.
  • Li, Q., A. Imhof, T. N. Collingwood, F. D. Urnov, and A. P. Wolffe. 1999. p300 stimulates transcription instigated by ligand-bound thyroid hormone receptor at a step subsequent to chromatin disruption. EMBO J. 18:5634–5652.
  • Ma, D., J. P. H. Shield, W. Dean, I. Leclerc, C. Knauf, R. Burcelin, G. A. Rutter, and G. Kelsey. 2004. Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM. J. Clin. Investig. 114:339–348.
  • Ma, H., C. Nguyen, K. S. Lee, and M. Kahn. 2005. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression. Oncogene 24:3619–3631.
  • Mackay, J. P., and M. Crossley. 1998. Zinc fingers are sticking together. Trends Biochem. Sci. 23:1–4.
  • Mattar, P., O. Britz, C. Johannes, M. Nieto, L. Ma, A. Rebeyka, N. Klenin, F. Polleux, F. Guillemot, and C. Schuurmans. 2004. A screen for downstream effectors of Neurogenin2 in the embryonic neocortex. Dev. Biol. 273:373–389.
  • Matthews, J. M., and M. Sunde. 2002. Zinc fingers—folds for many occasions. IUBMB Life 54:351–355.
  • Miyamoto, S., T. Suzuki, S. Muto, K. Aizawa, A. Kimura, Y. Mizuno, T. Nagino, Y. Imai, N. Adachi, M. Horikoshi, and R. Nagai. 2003. Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain. Mol. Cell. Biol. 23:8528–8541.
  • Onate, S. A., S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354–1357.
  • Pagotto, U., T. Arzberger, E. Ciani, F. Lezoualc'h, C. Pilon, L. Journot, D. Spengler, and G. K. Stalla. 1999. Inhibition of Zac1, a new gene differentially expressed in the anterior pituitary, increases cell proliferation. Endocrinology 140:987–996.
  • Pagotto, U., T. Arzberger, M. Theodoropoulou, Y. Grubler, C. Pantaloni, W. Saeger, M. Losa, L. Journot, G. K. Stalla, and D. Spengler. 2000. The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas. Cancer Res. 60:6794–6799.
  • Robertson, J. D., S. Orrenius, and B. Zhivotovsky. 2000. Review: nuclear events in apoptosis. J. Struct. Biol. 129:346–358.
  • Rouaux, C., N. Jokic, C. Mbebi, S. Boutillier, J. P. Loeffler, and A. L. Boutillier. 2003. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J. 22:6537–6549.
  • Rozenfeld-Granot, G., J. Krishnamurthy, K. Kannan, A. Toren, N. Amariglio, D. Givol, and G. Rechavi. 2002. A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1. Oncogene 21:1469–1476.
  • Shaywitz, A. J., S. L. Dove, J. M. Kornhauser, A. Hochschild, and M. E. Greenberg. 2000. Magnitude of the CREB-dependent transcriptional response is determined by the strength of the interaction between the kinase-inducible domain of CREB and the KIX domain of CREB-binding protein. Mol. Cell. Biol. 20:9409–9422.
  • Smith, J. L., W. J. Freebern, I. Collins, A. De Siervi, I. Montano, C. M. Haggerty, M. C. McNutt, W. G. Butscher, I. Dzekunova, D. W. Petersen, E. Kawasaki, J. L. Merchant, and K. Gardner. 2004. Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment. Proc. Natl. Acad. Sci. USA 101:11554–11559.
  • Soutoglou, E., G. Papafotiou, N. Katrakili, and I. Talianidis. 2000. Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins. J. Biol. Chem. 275:12515–12520.
  • Soutoglou, E., B. Viollet, M. Vaxillaire, M. Yaniv, M. Pontoglio, and I. Talianidis. 2001. Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity. EMBO J. 20:1984–1992.
  • Spengler, D., M. Villalba, A. Hoffmann, C. Pantaloni, S. Houssami, J. Bockaert, and L. Journot. 1997. Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain. EMBO J. 16:2814–2825.
  • Suzuki, T., A. Kimura, R. Nagai, and M. Horikoshi. 2000. Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding. Genes Cells 5:29–41.
  • Theodoropoulou, M., J. Zhang, S. Laupheimer, M. Paez-Pereda, C. Erneux, T. Florio, U. Pagotto, and G. K. Stalla. 2006. Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing zac1 expression. Cancer Res. 66:1576–1582.
  • Thompson, P. R., D. Wang, L. Wang, M. Fulco, N. Pediconi, D. Zhang, W. An, Q. Ge, R. G. Roeder, J. Wong, M. Levrero, V. Sartorelli, R. J. Cotter, and P. A. Cole. 2004. Regulation of the p300 HAT domain via a novel activation loop. Nat. Struct. Mol. Biol. 11:308–315.
  • Valente, T., and C. Auladell. 2001. Expression pattern of Zac1 mouse gene, a new zinc-finger protein that regulates apoptosis and cellular cycle arrest, in both adult brain and along development. Mech. Dev. 108:207–211.
  • Valente, T., M. I. Dominguez, A. Bellmann, L. Journot, I. Ferrer, and C. Auladell. 2004. Zac1 is up-regulated in neural cells of the limbic system of mouse brain following seizures that provoke strong cell activation. Neuroscience 128:323–336.
  • Valente, T., F. Junyent, and C. Auladell. 2005. Zac1 is expressed in progenitor/stem cells of the neuroectoderm and mesoderm during embryogenesis: differential phenotype of the Zac1-expressing cells during development. Dev. Dyn. 233:667–679.
  • Varrault, A., B. Bilanges, D. J. G. Mackay, E. Basyuk, B. Ahr, C. Fernandez, D. O. Robinson, J. Bockaert, and L. Journot. 2001. Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus. J. Biol. Chem. 276:18653–18656.
  • Varrault, A., E. Ciani, F. Apiou, B. Bilanges, A. Hoffmann, C. Pantaloni, J. Bockaert, D. Spengler, and L. Journot. 1998. hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer. Proc. Natl. Acad. Sci. USA 95:8835–8840.
  • Vettese-Dadey, M., P. A. Grant, T. R. Hebbes, C. Robinson, C. D. Allis, and J. L. Workman. 1996. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. EMBO J. 15:2508–2518.
  • Voz, M. L., J. Mathys, K. Hensen, H. Pendeville, V. Van, I. H. C. Van, M. Chavez, D. B. Van, M. B. De, Y. Moreau, and d. Van, V. 2004. Microarray screening for target genes of the proto-oncogene PLAG1. Oncogene 23:179–191.
  • Wang, W., S. B. Lee, R. Palmer, L. W. Ellisen, and D. A. Haber. 2001. A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1. J. Biol. Chem. 276:16810–16816.
  • Waterborg, J. H., and H. R. Matthews. 1994. Fluorography of polyacrylamide gels containing tritium. Methods Mol. Biol. 32:163–167.
  • Yan, Z., S. Choi, X. Liu, M. Zhang, J. J. Schageman, S. Y. Lee, R. Hart, L. Lin, F. A. Thurmond, and R. S. Williams. 2003. Highly coordinated gene regulation in mouse skeletal muscle regeneration. J. Biol. Chem. 278:8826–8836.
  • Yang, M. C., J. C. Weissler, L. S. Terada, F. Deng, and Y. S. Yang. 2005. Pleiomorphic adenoma gene-like-2, a zinc finger protein, transactivates the surfactant protein-C promoter. Am. J. Respir. Cell Mol. Biol. 32:35–43.
  • Yao, Y. L., W. M. Yang, and E. Seto. 2001. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol. Cell. Biol. 21:5979–5991.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.